New asthma drug shows promise in Long-Term safety check
Disease control
Ongoing
This study looks at the long-term safety and effectiveness of verekitug, an experimental drug, for adults with severe asthma. All 396 participants had already completed the earlier VALIANT trial. The main goal is to track side effects and asthma flare-ups over time.
Phase: PHASE2 • Sponsor: Upstream Bio Inc. • Aim: Disease control
Last updated May 17, 2026 14:00 UTC